AstraZeneca-Bristol Myers merger talks explained
Pharma investors reeled this week from reports that AstraZeneca held merger talks with U.S. rival Bristol Myers Squibb,…
AstraZeneca stock falls as investors balk at reported Bristol Myers tie-up
AstraZeneca shares dropped as much as 7% on Monday after reports that the company had discussed a potential…
CNBC UK Exchange: Diageo’s turnaround test
This report is from this week’s CNBC UK Exchange newsletter. Like what you see? You can subscribe here. The…
AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
HSBC loses conviction in leading drugmaker, forecasts ‘tough path’ ahead
HSBC has lost conviction in its buy rating for AstraZeneca and forecasts a “tough path ahead” for the…
Stocks making the biggest moves premarket: AZN, PEP, CRM, LEVI
Check out the companies making the biggest moves in premarket trading: AstraZeneca — The biopharmaceutical company tumbled 8%…
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…